NO20090326L - DNA fragmenteringsanalyse - Google Patents

DNA fragmenteringsanalyse

Info

Publication number
NO20090326L
NO20090326L NO20090326A NO20090326A NO20090326L NO 20090326 L NO20090326 L NO 20090326L NO 20090326 A NO20090326 A NO 20090326A NO 20090326 A NO20090326 A NO 20090326A NO 20090326 L NO20090326 L NO 20090326L
Authority
NO
Norway
Prior art keywords
dna fragmentation
fragmentation analysis
methods
analysis
modify
Prior art date
Application number
NO20090326A
Other languages
English (en)
Inventor
Tina Garyantes
Zhuyin Li
Yongping Yan
Justin Anthony Yu
Asher Zilberstein
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of NO20090326L publication Critical patent/NO20090326L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57505—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the blood, e.g. leukaemia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Det tilveiebringes metoder for detektering av midler som modifiserer dannelsen av DNA fragmentering i celler. Metodene som beskrives er konfigurert i et analyseformat som kan tilpasses høye gjennomløpsavsøkningsanvendelser.
NO20090326A 2006-06-21 2009-01-21 DNA fragmenteringsanalyse NO20090326L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80540906P 2006-06-21 2006-06-21
PCT/US2007/071619 WO2007149896A2 (en) 2006-06-21 2007-06-20 Dna fragmentation assay

Publications (1)

Publication Number Publication Date
NO20090326L true NO20090326L (no) 2009-01-21

Family

ID=38834338

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090326A NO20090326L (no) 2006-06-21 2009-01-21 DNA fragmenteringsanalyse

Country Status (16)

Country Link
US (1) US20100248224A1 (no)
EP (1) EP2035558A4 (no)
JP (1) JP2009540834A (no)
KR (1) KR101140240B1 (no)
CN (1) CN101454450A (no)
AR (1) AR061550A1 (no)
AU (1) AU2007261007B2 (no)
BR (1) BRPI0713727A2 (no)
CA (1) CA2655121A1 (no)
IL (1) IL196011A (no)
MX (1) MX2008014911A (no)
MY (1) MY149870A (no)
NO (1) NO20090326L (no)
RU (1) RU2486247C2 (no)
TW (1) TW200817523A (no)
WO (1) WO2007149896A2 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105001665B (zh) * 2014-04-15 2017-05-31 苏州嘉恒生物科技有限公司 一种新型核酸染料的制备及其应用
CN112578107A (zh) * 2020-12-08 2021-03-30 上海思路迪生物医学科技有限公司 一种高通量测定双链dna浓度的工作液及其测定方法
CN117867090B (zh) * 2024-03-12 2024-06-11 北京雅康博生物科技有限公司 Dna片段化水平定量用标准品及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4499918B2 (ja) * 1998-03-27 2010-07-14 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 高スループット・スクリーニング用の小型化マイクロタイタ・プレート
EP1433789A1 (en) * 2002-12-24 2004-06-30 Aponetics AG Pyrrolopyrazines and their use as selective apoptosis inducers
KR20040080452A (ko) * 2003-03-11 2004-09-20 구성자 뇨 중 5-하이드록시트립토폴을 이용한 한국형 음주측정용바이오마커
CA2553704C (en) * 2004-02-11 2011-04-19 Basilea Pharmaceutica Ag Substituted benzimidazoles and their use for inducing apoptosis
KR20070051327A (ko) * 2007-03-13 2007-05-17 인디부메드 게엠베하 직장결장 샘종 및／또는 암종에 대한 바이오마커로서의트랜스사이레틴의 용도； 검출 및 검사 시스템을 위한 방법

Also Published As

Publication number Publication date
IL196011A (en) 2013-07-31
US20100248224A1 (en) 2010-09-30
CA2655121A1 (en) 2007-12-27
WO2007149896A2 (en) 2007-12-27
WO2007149896A3 (en) 2008-02-14
CN101454450A (zh) 2009-06-10
IL196011A0 (en) 2009-09-01
JP2009540834A (ja) 2009-11-26
EP2035558A2 (en) 2009-03-18
BRPI0713727A2 (pt) 2012-10-30
MY149870A (en) 2013-10-31
EP2035558A4 (en) 2009-11-11
AU2007261007A1 (en) 2007-12-27
RU2009101769A (ru) 2010-07-27
AU2007261007B2 (en) 2013-05-23
KR101140240B1 (ko) 2012-04-26
MX2008014911A (es) 2008-12-09
TW200817523A (en) 2008-04-16
KR20090026297A (ko) 2009-03-12
RU2486247C2 (ru) 2013-06-27
AR061550A1 (es) 2008-09-03

Similar Documents

Publication Publication Date Title
WO2009114185A3 (en) Methods and compositions for translational profiling and molecular phenotyping
EP1999247A4 (en) CELL CULTURAL DEVICES WITH ULTRADOOR POROUS MEMBRANE AND APPLICATIONS THEREOF
EP1994142A4 (en) METHOD AND COMPOSITIONS FOR FAST ISOLATION OF SMALL RNA MOLECULES
EP1882736A4 (en) CELL CULTURE CONTAINER
EP1896073A4 (en) ANTI-IL-23 ANTIBODIES, COMPOSITIONS, METHODS AND USES
EP4300100A3 (en) Reagent storage in an assay device
DK2089343T3 (da) Click-kemi til fremstilling af reportermolekyler
WO2007065025A3 (en) Method of dna analysis using micro/nanochannel
WO2009129505A3 (en) Compositions, methods, and kits using synthetic probes for determining the presence of a target nucleic acid
IL198185A (en) Testing Devices, Methods for Preparing and Testing Methods
DK2089516T3 (da) Fremgangsmåder til at forbedre indføringen af DNA i bakterielle celler
MX2010008919A (es) Metodos y composiciones para detectar mocroorganismos.
DE602006015793D1 (de) Proteolipidmembran und lipidmembranen-biosensor
NO20082240L (no) GLP-2 imitatorstoff, polypeptider, sammensetninger, fremgangsmater og anvendelser
WO2008130394A3 (en) Array for detecting microbes
WO2007114986A3 (en) Cooperative probes and methods of using them
EA200970407A1 (ru) Ингибиторы киназ mapk/erk
ATE487245T1 (de) Rehydrierung von brennstoffzellen
WO2008043543A3 (en) Nucleic acid beacons for fluorescent in-situ hybridisation and chip technology
ATE505725T1 (de) Nukleinsäuredetektion mit poröser polymerelektrode
EP2245160A4 (en) CELL SURFACE PRESENTATION OF PROTEINS
DK2511369T3 (da) Proteasestabile cellevægslyserende enzymer
NO20090326L (no) DNA fragmenteringsanalyse
EP1988804A4 (en) MICRO FLUID CELL CULTURE MEDIA
BRPI0604761A (pt) detecção de metilação de gene

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application